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Abstract: Aging and excessive adiposity are both associated with an increased risk of developing multiple chronic diseases,
which drive ever increasing health costs. The main aim of this study was to determine the net (non‐estimated) health costs of
excessive adiposity and associated age‐related chronic diseases. We used a prevalence‐based approach that combines
accurate data from the Health Search CSD‐LPD, an observational dataset with patient records collected by Italian general
practitioners and up‐to‐date health care expenditures data from the SiSSI Project. In this very large study, 557,145 men and
women older than 18 years were observed at different points in time between 2004 and 2010. The proportion of younger and
older adults reporting no chronic disease decreased with increasing BMI. After adjustment for age, sex, geographic residence,
and GPs heterogeneity, a strong J‐shaped association was found between BMI and total health care costs, more pronounced
in middle‐aged and older adults. Relative to normal weight, in the 45‐64 age group, the per‐capita total cost was 10% higher
in overweight individuals, and 27 to 68% greater in patients with obesity and very severe obesity, respectively. The
association between BMI and diabetes, hypertension and cardiovascular disease largely explained these elevated costs.

INTRODUCTION

disease (CVD), osteoarthritis, depression and certain
prevalent cancers (i.e. colon, breast, and prostate) [4].
The diagnosis and treatment of these common and
preventable chronic diseases places a significant burden
on National Health Service budgets. However, little is
known about the true (non-estimated) impact of body
mass index (BMI) on the inpatient and outpatient health
care costs for these adiposity-associated chronic
diseases. This study has several advantages over most
existing studies. The majority of studies published so
far have estimated the total health care costs of obesity
by modelling group and individual level data with
various degree of representativeness at national level,
often relying on self-reported clinical information and

The current obesity epidemic in an increasingly aging
population presents health, long-term care, and welfare
systems with new challenges [1]. Increased
consumption of energy-dense, nutrient-poor foods and a
sedentary lifestyle have led to this sharp and
unprecedented rise in the rates of overweight and
obesity, which has been estimated to increase both
direct and indirect health care costs due to lost
productivity [2, 3]. Aging and excess adiposity are both
well-established risk factors for the development and
progression of several chronic diseases, including type 2
diabetes, hypertension, dyslipidaemia, cardiovascular
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proxies of medical expenditures [5-11]. In this study, we
used a patient-based approach combining health care cost
data and accurate anthropometric and clinical
informations collected by general practitioners in a large
representative longitudinal sample of more than 550
thousand Italian men and women, homogeneously
distributed across all Italian regions. Moreover, Italy is an
ideal setting for this type of analysis, since its National
Health Service provides universal and substantially free
health care access to all citizens, with 87% of medical
services publicly financed [12], avoiding problems of
patient selection associated with insurance based health
care systems. Finally, by modelling this data with a
seemingly unrelated regression equation (SURE)
statistical method, we were able to disentangle the direct
and indirect (i.e. obesity-associated diseases) impact of
BMI on health care system spending.

J-shaped association between BMI and overall (direct
and indirect) total health care expenditure, which was
stronger among middle-aged and elderly individuals.
Total health care expenditures among the middle-aged
(45-64 yrs old) individuals with overweight, obesity,
severe obesity and very severe obesity were 10%, 27%,
52% and 68% higher, respectively, than among those
with BMI of 18.5 to 24.9 (p=0.0001) (third panel of
Table 3). In absolute terms, outpatient costs were more
strongly related to BMI among individuals aged 45 to 64
years. The annual mean costs among the overweight,
obesity, severe obesity and very severe obesity patients
were 76, 159, 237, and 310 euro higher, respectively,
than in normo-weight individuals, which translates in a
cost increase of about 18%, 38%, 57% and 75% for each
BMI category, respectively (third panel of Table 2). In
contrast, total costs were more strongly related to BMI
among individuals aged 65+ years. The annual
differential mean costs among the patients with
overweight, obesity, severe obesity and very severe
obesity were 75, 302, 719, and 790 euro higher,
respectively, than in normal weight individuals (fourth
panel of Table 3). Total overall (direct and indirect) costs
were also significantly higher in underweight individuals
than in normal weight individuals in all subsamples
(Table 3). In particular, annual mean total costs among all
underweight individuals were 138 euro higher than in the
normo-weight subjects, which translates in a cost
increase of 13% (first panel of Table 3).

RESULTS
Sample descriptive statistics
Table 1 summarizes the breakdown of the variables
according to BMI classes, showing large differences in
demographic and clinical parameters such as age and
prevalence of comorbidities. Hypertension and type 2
diabetes were the most common BMI-associated health
conditions and their prevalence shows a strong increase
with increasing BMI (p=0.0001 for all BMI categories
with respect to normal weight individuals). In addition,
the prevalence of dyslipidaemia, CVD and arthrosis
were higher in individuals with overweight and obesity
than in normal weight individuals in both younger (<55
yrs) and older (>55 yrs) patients (p=0.0001 for all BMI
categories with respect to normal weight individuals).
There was a clear negative association between BMI
and the proportion of individuals with no chronic
disease (p=0.0001 for all BMI categories with respect to
normal weight individuals). In contrast, the proportion
of individuals affected by 2 or more chronic diseases
increased sharply with raising BMI.

Indirect and direct costs
The share of indirect costs within overall outpatient
costs was the largest in overweight and obese men and
women aged 45-64 years (Table 2). Moreover, the
indirect costs of the underweight subjects were lower
than those of the normo-weight individuals for each age
group, and this differential was more pronounced in the
elderly, amounting to 11% (Table 2).
In terms of total outpatient and inpatient health
expenditure, direct costs were negative in the overweight
and obesity groups, suggesting that after correcting for
BMI-related pathologies, these patients on average had
lower health care expenditures than normo-weight
individuals. This direct cost differential turned positive
for the category with severe and very severe obesity, and
was particularly pronounced in the elderly (Table 3).
Moreover, the total indirect costs in the underweight
individuals were significantly lower than in the normoweight subjects, and this differential was particularly
high in the elderly (fourth panel of Table 3). Finally, the
total direct costs in the underweight men and women
were substantially higher than in the elderly normoweight individuals.

BMI and healthcare costs
Table 2 and Table 3 present the coefficient estimates of
indirect (i.e. obesity-associated diseases), direct and
differential effects of BMI on outpatient and total health
care costs for each age group. The tables report marginal
effects for each BMI category within each age specific
subsample, as well as the percentage differences of the
marginal effect estimate with respect to the annual
average expenditure of normo-weight individuals.
As shown in Figure 1, after adjusting for age, sex,
geographic residence, and GPs heterogeneity, there was a
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Figure 1. Total (a) and outpatient (b) health care expenditure. Decomposition of differences in health care expenditure (direct,
indirect and overall costs) by age group and BMI category compared to normal‐weight individuals (euro per year) for outpatient (b) and total
(a) health expenditure. Note: ‐ Indirect marginal effects for each BMI category were computed as the sum of nonlinear combinations of
parameters estimated within each pathology‐specific equation with the respective pathology‐specific parameter estimated within the health
expenditure equation. ‐ Direct marginal effects for each BMI category were obtained as relative parameter estimates from the health expenditure
equation. ‐ Overall marginal effects for each BMI category was computed as the sum of the respective direct and indirect marginal effects.
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Table 1. Demographic and clinical characteristics of individuals 18 years or older, by
BMI categories

BMI

Under
weight
(15.0018.49)

Normal
weight
(18.5024.99)

Over
Weight
(25.0029.99)

Obesity
class I
(30.0034.99)

Obesity
class II
(35.0039.99)

Obesity
class III
(≥ 40.00)

72032
1103594
997802
390109
105731
35943
Sample size
17.5*
22.3
27.2*
32*
36.9*
43.6*
Mean BMI (kg/m2)
82.3%*
61.0%
44.8%*
50.2%*
62.4%*
71.7%*
Gender (% female)
39*
48
56*
57*
56*
54*
Mean age (yrs)
Age group (%)
25%*
10%
3%*
2%*
2%*
3%*
18-24
28%*
17%
8%*
7%*
7%*
8%*
25-34
19%*
20%
15%*
14%*
14%*
15%*
35-44
9%*
17%
19%*
19%*
20%*
21%*
45-54
6%*
13%
21%*
24%*
25%*
26%*
55-64
6%*
11%
19%*
21%*
21%*
19%*
65-74
8%*
10%
14%*
14%*
12%*
8%*
75+
Comorbidities (%)
Age group under 55
0.4%*
1.1%
3.5%*
7.3%*
12.1%*
16.7%*
Diabetes
1.9%*
6.4%
17.4%*
27.8%*
36.5%*
42.5%*
Hypertension
1.9%*
5.4%
11.6%*
13.3%*
12.0%*
9.4%*
Dyslipidemia
0.2%*
0.6%
1.5%*
2.0%*
2.2%*
2.0%*
CVD
4.7%*
4.0%
3.9%*
4.6%*
5.6%*
6.7%*
Depression
0.5%*
0.6%
0.6%
0.7%
0.7%
0.7%
Cancers
0.9%*
1.2%
2.0%*
2.7%*
3.7%*
4.9%*
Arthrosis
Age group over 55
5.6%*
12.5%
19.9%*
28.0%*
35.0%*
38.7%*
Diabetes
38.9%*
49.4%
61.9%*
72.0%*
78.9%*
82.8%*
Hypertension
18.8%*
26.9%
30.3%*
29.8%*
28.0%*
23.1%*
Dyslipidemia
9.9%*
11.4%
13.9%*
14.7%*
14.6%*
12.3%*
CVD
10.4%*
8.0%
6.7%*
7.2%*
8.1%
8.3%
Depression
6.5%*
6.0%
5.7%*
5.3%*
4.7%*
4.1%*
Cancer
6.5%*
8.0%
10.2%*
13.1%*
15.9%*
18.0%*
Arthrosis
No. of comorbidities
Age group under 55
90.5%*
83.5%
68.5%*
58.1%*
50.3%*
45.4%*
0
8.7%*
14.0%
24.0%*
29.0%*
31.8%*
33.3%*
1
0.8%*
2.2%
6.1%*
9.9%*
13.4%*
15.5%*
2
0.1%*
0.3%
1.4%*
3.1%*
4.4%*
5.8%*
>=3
Age group over 55
37.6%*
28.0%
19.3%*
13.4%*
9.9%*
8.5%*
0
37.0%
36.6%
35.4%*
33.1%*
31.0%*
31.1%*
1
18.4%*
23.6%
28.0%*
30.8%*
32.3%*
33.8%*
2
7.1%*
11.8%
17.4%*
22.8%*
26.8%*
26.6%*
>=3
44%*
40%
34%*
31%*
31%*
28%*
Smokers (%)
8124
138211
135669
54825
15007
5013
(subsample in which
smoking information
was available)
* p<0.01, † p<0.05, ‡ p<0.1, each p value refers to a t test for equality of means for each category
with respect to normal weight category
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Figure 2. Total (a) and outpatient (b) indirect health care expenditure. Decomposition of indirect health care
expenditure by pathology, age group and BMI category compared to normo‐weight individuals (euro per year) for outpatient
(b) and total (a) health expenditure. Note: Pathology specific indirect marginal effects for each BMI category were computed as
the nonlinear combinations of parameters estimated within each pathology‐specific equation with the respective pathology‐
specific parameter estimated within the health expenditure equation.
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Relative effects of BMI and adiposity-associated
comorbidities on health care costs

overall BMI-related costs both in terms of outpatient
and total health care expenditures. Moreover, as shown
in figure 2, when hypertension, diabetes and CVD were
accounted for, the age-adjusted relation between BMI
and total and outpatient health care costs was to a large
extent eliminated.

As shown in figure 1, based on SURE analysis, the
indirect costs of excess body weight in individuals with
overweight and obesity explain the great majority of

Table 2. Effects of BMI on “Outpatient” health expenditure with respect to normo‐weight individuals
Indirect

Direct

Overall

%
% difference
difference
Marginal
from the
Marginal effect
from the
effect
mean
mean
Full sample (N=2705211), average estimated expenditure = 445 euro
Marginal
effect

% difference
from the mean

Underweight

-8.918***

-2%

12.66***

3%

3.745*

1%

Overweight

46.19***

10%

-1.650**

0%

44.54***

10%

Obesity

98.07***

22%

12.51***

3%

110.6***

25%

Severe obesity

139.3***

31%

33.77***

8%

173.0***

39%

Very severe obesity

159.3***

36%

69.48***

16%

228.7***

51%

18-44 (N=934147), average estimated expenditure = 173 euro
Underweight

-6.019***

-3%

-8.615***

-5%

-14.63***

-8%

Overweight

18.08***

10%

10.40***

6%

28.48***

17%

Obesity

39.05***

23%

18.44***

11%

57.48***

33%

Severe obesity

63.34***

37%

30.43***

18%

93.76***

54%

Very severe obesity

91.40***

53%

73.45***

43%

164.8***

95%

45-64 (N=990831), average estimated expenditure = 416 euro
Underweight

-33.64***

-8%

30.61***

7%

-3.034

-1%

Overweight

74.71***

18%

1.289

0%

76.00***

18%

Obesity

145.1***

35%

14.16***

3%

159.3***

38%

Severe obesity

203.9***

49%

33.27***

8%

237.2***

57%

Very severe obesity

236.3***

57%

73.93***

18%

310.2***

75%

Underweight

-84.66***

-11%

-0.941

0%

-85.60***

-11%

Overweight

65.49***

8%

5.145***

1%

70.64***

9%

Obesity

115.8***

15%

25.25***

3%

141.1***

18%

Severely obesity

145.9***

18%

56.22***

7%

202.1***

25%

Very severe obesity

138.3***

17%

78.01***

10%

216.3***

27%

65+ (N=780233), average estimated expenditure = 796 euro

- ***p<0.01, ** p<0.05, * p<0.1, each p value refers to a t test for equality of means for each category with respect to
normal weight category.
- Average estimated expenditure for each sample was obtained as the predicted expenditure from the health expenditure
equation, calculated for the normal weight individuals, and at means of all other regressors.
- Indirect marginal effects for each BMI category were computed as the sum of nonlinear combinations of parameters
estimated within each pathology-specific equation with the respective pathology-specific parameter estimated within the
health expenditure equation.
- Direct marginal effects for each BMI category were obtained as relative parameter estimates from the health
expenditure equation.
- Overall marginal effects for each BMI category was computed as the sum of the respective direct and indirect marginal
effects.
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Table 3. Effects of BMI on “Total Outpatient and Inpatient” health expenditure with respect to normo‐
weight individuals
Indirect

Direct

Overall

%
% difference
Marginal
difference
Marginal
Marginal
from
effect
from
effect
effect
the mean
the mean
Full sample (N=2705211) , average estimated expenditure = 1092 euro

% difference
from
the mean

Underweight

-15.92***

-1%

154.0***

14%

138.1***

13%

Overweight

104.0***

10%

-66.52***

-6%

37.44***

3%

Obesity

237.3***

22%

-43.89***

-4%

193.4***

18%

Severe obesity

351.2***

32%

95.02***

9%

446.2***

41%

Very severe obesity

417.1***

38%

133.0***

12%

550.1***

50%

18-44 (N=934147) , average estimated expenditure = 399 euro
Underweight

-10.23***

-3%

72.71***

18%

62.49***

16%

Overweight

30.42***

8%

-8.392***

-2%

22.03***

6%

Obesity

66.72***

17%

5.606**

1%

72.32***

18%

Severe obesity

108.8***

27%

47.43***

12%

156.3***

39%

Very severe obesity

157.3***

39%

144.0***

36%

301.3***

75%

Underweight

-54.25***

-6%

180.0***

21%

125.7***

14%

Overweight

128.2***

15%

-45.25***

-5%

82.92***

10%

Obesity

257.0***

30%

-22.30***

-3%

234.7***

27%

Severe obesity

370.1***

43%

82.05***

9%

452.2***

52%

Very severe obesity

436.8***

50%

156.2***

18%

593.0***

68%

45-64 (N=990831) , average estimated expenditure = 867 euro

65+ (N=780233) , average estimated expenditure = 2193 euro
Underweight

-235.1***

-11%

468.4***

Overweight
Obesity

21%

233.4***

11%

202.2***

9%

-127.3***

-6%

74.87***

3%

381.9***

17%

-79.79***

-4%

302.1***

14%

Severe obesity

504.0***

23%

215.2***

10%

719.3***

33%

Very severe obesity

524.6***

24%

265.5***

12%

790.1***

36%

- ***p<0.01, ** p<0.05, * p<0.1, each p value refers to a t test for equality of means for each category with respect to
normal weight category
- Average estimated expenditure for each sample was obtained as the predicted expenditure from the health expenditure
equation, calculated for the normal-weight individuals, and at means of all other regressors.
- Indirect marginal effects for each BMI category were computed as the sum of nonlinear combinations of parameters
estimated within each pathology-specific equation with the respective pathology-specific parameter estimated within
the health expenditure equation.
- Direct marginal effects for each BMI category were obtained as relative parameter estimates from the health
expenditure equation.
- Overall marginal effects for each BMI category was computed as the sum of the respective direct and indirect
marginal effects.
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expenditure (hospitalizations) was accounted for, the 65+
age group patients generated in absolute terms the
majority of the BMI related health care costs.

DISCUSSION
In this study, we evaluated the disease burden, and the
direct and indirect effects of BMI on health care costs,
in a large population of 557,145 men and women for
whom accurate anthropometric, clinical and medical
cost data collected by general practitioners were
available. First, our data show a sharp increase in the
proportion of individuals affected by 2 or more ageassociated chronic diseases with raising BMI. Second,
our data show that after adjusting for age, sex,
geographic residence, and GPs heterogeneity, BMI still
has a relevant effect on both inpatient and outpatient
health care expenditure. We found a strong J-shaped
association between BMI and total health care costs,
which was more pronounced in middle-aged and older
adults. Third, our results demonstrated that
hypertension, diabetes and CVD account for the largest
share of outpatient and total health care expenditures.

It is essential, however, to establish the extent to which
one or more obesity-related medical conditions may
account for the variation in health care costs by BMI. Our
sophisticated multivariate regression SURE analysis
indicated that much of the increased costs can be
attributed to three very prevalent chronic diseases:
hypertension, type 2 diabetes and CVD. These data are in
agreement with previous estimates of other studies [32,
33]. However, this does not mean that BMI is not related
to increased health care expenditure through other
channels, because in our study individuals with severe
and very severe obesity had high direct health care costs,
net of the frequent adiposity-related medical conditions.
The prevalence of overweight and obesity in Italy, as in
many other developed and developing countries, has
been increasing steadily in the last few years [1, 2, 34].
Our data show that the rise in body weight is associated
with a strong increase in the prevalence of several
chronic diseases, including type 2 diabetes, hypertension, dyslipidemia, CVD, depression and arthrosis,
especially in individuals aged 55+ years. Moreover, our
data show that as BMI increases, the percentage of
younger and older adults with two or more adiposityrelated medical conditions increases several fold,
whereas the proportion of individuals with no chronic
diseases diminishes by 2 fold in the 18 to 55-year-old
age group and by 3 folds in individuals over 55-yearsold.

Many studies have attempted to estimate the health care
costs attributable to excess body weight. However, most
published studies so far have estimated BMI-related
costs by using a top-down approach which quantifies
attributable fractions of costs associated with adiposityrelated diseases by modelling group and individual level
data collected from National Health interview surveys
[5-11]. Moreover, in these studies the determinants of
BMI and the prevalence of chronic diseases were
mostly self-reported and, therefore, subjected to bias
[31]. To our knowledge, this is the first study to
determine the direct and indirect health care costs by
using a prevalence-based approach that combines data
from a large observational dataset, containing
computer-based patient records with accurate
anthropometric and clinical information and precise
medical cost data collected by general practitioners. Our
data are generally in line with the estimates of other
studies [21, 22, 25] showing that total health care
expenditure of the overweight is around 3% higher than
in normal weight individuals, while patients with
obesity, severe obesity and very severe obesity spend
respectively 18%, 41% and 50% more than their
normal-weight counterparts.

The results of our study provide firm evidence that the
impact that excess body weight has on a set of chronic
diseases, represents the largest component of health care
expenditures. Considering our marginal BMI-related
costs and the official statistics of obesity prevalence of
the Italian adult population [35], we estimated that the
overall BMI-related costs amount approximately to 4%
of total health care expenditure of the Italian national
health service (i.e. 4.5 billions of euro per year). This
estimate, based on the self- and under- reported official
prevalence rates of BMI among the Italian population
represents a lower bound of the real costs of excessive
adiposity in Italy. In fact, this estimate is slightly lower
than the 5-10% found for the USA [23, 26, 29, 30], and
4.5% for the UK [28], while somewhat higher than 2.33.5% found for Switzerland [27].

Interestingly, we found that BMI-related costs vary
substantially across age groups. With respect to normoweight individuals, the highest overall (direct plus
indirect) outpatient expenditure differentials in absolute
terms were found in the 45-64 age group, and in the 65+
age group for total out- and in-patient health care costs.
This finding suggests that outpatient health care
utilization in terms of drugs, medical visits and diagnostic
tests resulting from excess body weight is particularly
higher in the 45-64 age group. However, when inpatient
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heights, chronic disease diagnosis, test results, drug
prescriptions, outpatient diagnostic tests, specialist
visits and hospital admissions), collected for a large
sample of patients and entered in an up-to-date
computer-based database by trained GPs, is a major
strength of this study. In addition, it is important to
stress that the Italian National Health Service is a public
and universalistic system, which provides substantially
free health services for all citizens. According to OECD
Health Data, in 2012 about 87% of medical services in
Italy was publicly financed. This setting favours the
external validity of the study and minimizes the
selection problems related to presence of private
insurance plans. Finally, the use of a multi-equation
recursive model (SURE) to calculate the relative effects
of BMI and adiposity-associated chronic diseases on
health care costs represents another strength of this
study, since it provides better and more efficient
estimates of the cost of obesity and allows to study
direct and indirect effects of BMI of health care
expenditure. One major limitation of this study is the
lack of alternative measures of adiposity, such as waist
circumference or waist-hip ratio. Moreover, the analysis
could potentially benefit by introducing covariates such
as smoking or socio-economic status, enhancing the
precision of the coefficient estimates, which are not
available within this dataset. Finally, the estimates
might suffer from a downward bias, as the control group
includes individuals who, while not being affected by
the diseases included in this analysis, may have had
other pathologies, which may increase health
expenditure with respect to the overall population.

for participation in epidemiological studies, GPs should
meet “up-to-standard” quality criteria pertaining to the
levels of coding, prevalence of well-known diseases,
mortality rates, and years of recording [13]. The HS
database complies with the European Union guidelines
on the use of medical data for research, and has
previously been demonstrated to be a valid data source
for scientific research [14-16]. GPs collected this
information on daily basis. However, in this study the
records have been collapsed to obtain yearly aggregates.
Finally, these data have been merged, at patient level,
with data from the SiSSi (Simulazione Spesa Sanitaria
Italiana – Simulation of the Italian Health Care
Expenditure) project, which includes information on
prices and tariffs for drugs, outpatient visits, diagnostic
tests and hospitalization visits. By multiplying health
care service utilization data from the HS with price and
tariff data from the SiSSi project we obtained detailed
information on public health care expenditure at the
patient level [17-19].
Model structure. Obesity-related health care
expenditure is generally studied with a cost-regression
approach [20-30]. However, this method is likely to
produce biased estimates, since it does not analyze the
mechanisms at play between BMI and health care
expenditures. Therefore, we have built a multiequation recursive model within a Seemingly
Unrelated Regression Estimator (SURE) approach to
quantify: (1) indirect costs, resulting from the impact
that BMI has on a set of chronic diseases commonly
attributable to obesity, which in turn influence health
expenditure; and (2) direct costs, defined as the
residual impact of BMI independent of adiposityassociated chronic diseases, after adjusting for age,
sex, geographic residence, and GPs heterogeneity. The
statistical model consisted of eight equations,
estimated simultaneously, of which the first 7
represent the sets of obesity-related chronic diseases
(1) type 2 diabetes mellitus; (2) hypertension; (3)
dyslipidemia; (4) cardiovascular diseases: coronary
artery disease, ischemic stroke, congestive heart
failure; (5) cancers: breast, colon, and prostate cancer,
(6) arthrosis: hip and knee arthrosis; (7) depression,
while the last equation modeled the health care
expenditure as a function of the above chronic
conditions plus BMI.

METHODS
Sources of data. The present analysis was based on data
of 557,145 men and women, older than 18 years, who
were observed at different times between 2004 and
2010, amounting to a total of 2,705,211 observations.
The anthropometric and clinical data have been
extracted from the Health Search/CSD Patient Database
(HS), an Italian general practice registry that includes
data obtained from computer-based patient records of a
selected group of 700 general practitioners (GP),
homogeneously distributed across all Italian regions,
covering a patient population of over a 1.8 million
between 2004-2010. The GPs voluntarily agreed to
collect patient information and to attend specific
training courses for data entry [13]. The HS database
contains patient demographic data that are linked
through the use of an encrypted patient code with their
medical records (diagnoses, prescribed tests results),
drug prescription information (medication name, date of
filled prescription, and number of days’ supply),
hospital admissions, and date of death. To be considered
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Dependent variables. The empirical model comprised 8
equations, and hence there were 8 dependent variables:
7 dummy variables indicating the presence of one of the
selected diseases at patient level plus the per-capita
health care expenditure variable. We used two
definitions of health expenditure: “outpatient” health
care expenditure and “total” health care expenditure (i.e.
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inpatient and outpatient medical costs). Precise data on
health care expenditure were obtained from a merge of
Health Search CSD-LPD database with data on costs
and tariffs of drugs, outpatient visits, diagnostic tests,
and hospitalizations from the SiSSI Project.
Furthermore, since the Health Search CSD-LPD PCP’s
may underreport the events of hospital admissions, we
reweighted the Health Search CSD-LPD hospitalization
rates with the hospital admission data collected by the
Italian National Institute of Statistics (ISTAT). The
weighting procedure stratifies the patient population by
region, age (18-44, 45-64 and 65 and older), gender and
BMI level in order to match cell groups of individuals
in the Health Search CSD-LPD and ISTAT datasets.
Subsequently, average hospitalization costs for the same
cell groups were computed from the Hospital Discharge
dataset of the Italian Ministry of Health and assigned to
the Health Search CSD-LPD population.

diagnosis of pathologies and health expenditure
realization; X is a set of control variables including age,
gender, region of residence and year time dummies; and
GP is a vector of variables including physician
characteristics. Finally, εjit and ηit are idiosincratic error
terms. The assumption of the model is that error terms
are independent across time, but may have crossequation contemporaneous correlations. Thus we
assume that E[ εir εis | X ] = 0 whenever r ≠ s, whereas
E[ εir εjr | X ] = σij. Although Ordinary Least Squares
(OLS) estimate of our model parameters are consistent,
generally they are not as efficient as the SURE method,
which uses the feasible generalized least squares
(FGLS) method with a specific form of the variancecovariance matrix. The analysis was conducted
separately for the whole sample of patients as well as
for subsamples by age classes (18-44 year olds, 45-64
year olds and 65+ year olds). The coefficient estimates
were expressed as marginal effects. For the full sample,
the reference category was a male, resident of the
Piedmont region in North Italy, in the normal weight
BMI category, not affected by any of the pathologies
considered in the study, observed for the first time in
2004 and aged between 18 and 44. This last condition
was not considered when dealing with the subsamples
by ages. The parameter estimates described the impact
of each covariate on individual health care expenditure.
The statistical analysis was performed using Stata
software version 13 (Stata Corps).

Covariates. BMI was calculated as weight in kilograms
divided by the square of height in meters. Study
participants were divided in 6 groups with: normal
weight (BMI, 18.5-24.99 [the reference group]),
underweight (BMI between 15 and 18.49), overweight
(BMI, 25.0-29.99), obesity (BMI, 30.0-34.99), severe
obesity (BMI, 35.0-39.99) or very severe obesity (BMI
>40.0). Since health expenditure may differ due to GPs
practice heterogeneity, we controlled for GPs behavior,
including variables such as the average number of
patient contacts, the average number of prevention
visits, the number of overall patients registered with the
GPs practice and the average unit price of the
prescribed drugs. Finally, we accounted for patient
heterogeneity by controlling for age, gender, and region
of residence.

CONCLUSION
Based on one of the largest datasets used in this
literature, the results of this study reinforce the
concept that overweight and obesity increases the risk
of developing multiple and costly chronic diseases.
Our findings demonstrate the adverse impact of
increased BMI on outpatient and total healthcare costs,
especially in middle-aged and elderly individuals.
They also show that hypertension, type 2 diabetes and
CVD are responsible for a large part of these BMIrelated health care expenditures. The knowledge of
these costs will be useful for future economic analysis
of preventive and treatment interventions, such as
long-term, comprehensive national initiatives that
tackle the basic causes of poor diet quality and
sedentary lifestyles.

Statistical analysis. In econometrics, the seemingly
unrelated regression equations (SURE) model is a
generalization of a linear regression model that consists
of several regression equations, each having its own
dependent variable and potentially different sets of
exogenous explanatory variables [20]. Analytically, the
structure of a SURE model employed in this analysis
can be represented by the following 8 equation model:
Pjit = αj0 + βj BMI it-1 + δj X it + θj GPit + ε jit
HEit = θ0 + ∑7j=1λj Pjit + π BMI it-1 + ρ X it + σ GPit + ηit
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where j = 1,..,7 represents the sets of pathologies, i
stands for individuals, t =2004,...,2010 for years, and
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euro per year, BMI is the vector of body weight dummy
variables categories observed in the year preceding the
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